We can't find the internet
Attempting to reconnect
18540.1 IP-LS
18540.1 IP-LS
Résumé
Engineered arrestins as novel biosensors for drug-induced GPCR phosphorylation
Textes supplémentaires
Abstract
Promising drug candidates entering pre- and clinical trials account for more than 50% of the total Pharma R&D|spending and have a failure rate of 95%. About half of them target GPCRs, an important superfamily of|membrane receptors. For better and earlier assessment of quality, safety, and effectiveness of drug|candidates, we will develop cellular screening systems on a unique arrestin-engineering platform to enable|high-throughput dissection of drug-induced GPCR signaling.
Participants
Maria Waldhoer
Wirtschaftspartner
waldhoer@interaxbiotech.com
InterAx Biotech AG Maria Waldhoer PARK innovAARE 5234 Villigen AG CH
Gebhard Schertler
Kontaktperson
gebhard.schertler@psi.ch
PSI Paul Scherrer Institut Gebhard Schertler 5232 Villigen AG CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2016-06-30
- Date de fin
- 2019-11-30
- Coûts totaux approuvés
- CHF 493680.00
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%